Journal of Applied Physiology Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 78: 1745-1749, 1995;
8750-7587/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rimar, S.
Right arrow Articles by Gillis, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rimar, S.
Right arrow Articles by Gillis, C. N.

Journal of Applied Physiology, Vol 78, Issue 5 1745-1749, Copyright © 1995 by American Physiological Society

ARTICLES

Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung

S. Rimar and C. N. Gillis
Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

To determine the site of inhaled nitric oxide (NO)-induced pulmonary vasodilation, a double vascular occlusion technique was used with rabbit lungs ventilated and perfused at 20 ml/min with Krebs solution containing 3% dextran and 30 microM indomethacin. Inhaled NO (120 ppm for 3 min) reduced pulmonary vasoconstriction produced by U-46619 infusion (0.5-1.2 nmol/min), significantly decreasing total resistance (RT) [1,080 +/- 51 (SE) vs. 1,545 +/- 109 mmHg.l-1.min; P < 0.01]. Acetylcholine infusion (ACh; 2-5 nmol/min) and nitroglycerin (NTG; 0.35 mumol) likewise decreased RT. Arterial resistance (Ra) was also significantly less with inhaled NO, ACh, and NTG compared with U-46619 alone. Venous resistance (Rv), however, was unchanged. When the direction of perfusion was reversed in the lung, inhaled NO, ACh, and NTG significantly decreased RT compared with U-46619 alone, and Rv was also reduced by all three agents. After electrolysis-induced acute lung injury, inhaled NO significantly reduced both RT and Ra compared with U-46619 alone, whereas Rv was unaffected. Our results demonstrate that inhaled NO gas affects primarily the arterial (precapillary) component of the pulmonary circulation but, under conditions of extreme venous constriction, may dilate the postcapillary component as well.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
P. Fesler, A. Pagnamenta, J-L. Vachiery, S. Brimioulle, S. Abdel Kafi, A. Boonstra, M. Delcroix, R.N. Channick, L.J. Rubin, and R. Naeije
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Eur. Respir. J., January 1, 2003; 21(1): 31 - 36.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, H. Leuchte, F. Grimminger, W. Seeger, and D. Walmrath
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1361 - L1368.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Bentley, D. Rickaby, S. T. Haworth, C. C. Hanger, and C. A. Dawson
Pulmonary arterial dilation by inhaled NO: arterial diameter, NO concentration relationship
J Appl Physiol, November 1, 2001; 91(5): 1948 - 1954.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. L. Mundy and K. L. Dorrington
Inhibition of nitric oxide synthesis augments pulmonary oedema in isolated perfused rabbit lung
Br. J. Anaesth., October 1, 2000; 85(4): 570 - 576.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, C. Schudt, H. Tenor, F. Grimminger, W. Seeger, and D. Walmrath
Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 512 - 520.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. T. SCHERMULY, H. A. GHOFRANI, B. ENKE, N. WEISSMANN, F. GRIMMINGER, W. SEEGER, C. SCHUDT, and D. WALMRATH
Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1500 - 1506.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
R. J. Brilli, B. Krafte-Jacobs, D. J. Smith, D. Roselle, D. Passerini, A. Vromen, L. Moore, C. Szabo, and A. L. Salzman
Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension
J Appl Physiol, December 1, 1997; 83(6): 1968 - 1975.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Schütte, F. Grimminger, J. Otterbein, R. Spriestersbach, K. Mayer, D. Walmrath, and W. Seeger
Efficiency of Aerosolized Nitric Oxide Donor Drugs to Achieve Sustained Pulmonary Vasodilation
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 985 - 994.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. MLOT, F. VERMEULEN, M. MAGGIORINI, E. GILBERT, and R. NAEIJE
Site of Pulmonary Vasodilation by Inhaled Nitric Oxide in Microembolic Lung Injury
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 75 - 85.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online